Cancer Immunology & Immuno-Oncology

Immuno-oncology has transformed cancer treatment by harnessing the immune system to recognize and eliminate malignant cells. This session explores tumor immunology, immune escape, checkpoint inhibition, cellular immunotherapies, biomarkers, resistance mechanisms, and strategies to improve the effectiveness and safety of immune-based treatments.

Abstract Scope and Participation

Abstracts may include tumor immunology, checkpoint inhibitors, CAR-T therapy, TCR and TIL therapies, immune biomarkers, combination immunotherapy, immune resistance, tumor-immune interactions, and immune-related toxicities. Immunologists, oncologists, translational scientists, researchers, and biotechnology professionals are encouraged to participate.